Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Medidata Solutions Inc    MDSO

MEDIDATA SOLUTIONS INC (MDSO)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

Medidata Solutions Inc : Medidata Solutions Announces Two-for-One Stock Split

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/11/2013 | 12:31pm CEST

Medidata Solutions (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that its Board of Directors approved a two-for-one (2:1) split of the Company's common stock at a regularly scheduled board meeting on November 7, 2013. The stock split will be structured in the form of a stock dividend.

The record date for the stock split is December 2, 2013. Shareholders of record as of such date will receive one new share of common stock for each share that they own. The distribution of the new shares will be made on December 16, 2013, and trading on a split-adjusted basis is expected to begin on or about December 17, 2013.

Medidata had approximately 26.8 million shares of common stock outstanding as of November 7, 2013. The stock split will increase the common shares outstanding to approximately 53.6 million.

About Medidata Solutions

Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud TM brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of our global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.

Investors:
Medidata Solutions
Hulus Alpay, 212-419-1025
[email protected]
or
Media:
Medidata Solutions
Gail Janowitz, 212-918-1792
[email protected]


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDIDATA SOLUTIONS INC
06/20MEDIDATA SOLUTIONS, INC. : Completion of Acquisition or Disposition of Assets (f..
AQ
06/12E CLINICAL SOLUTION SOFTWARE MARKET : This research report on E Clinical Soluti..
AQ
06/12MEDIDATA SOLUTIONS, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
06/12MEDIDATA : Defines the Future of Life Sciences with Acquisition of SHYFT Analyti..
BU
05/31MEDIDATA SOLUTIONS, INC. : Submission of Matters to a Vote of Security Holders (..
AQ
05/31MEDIDATA : to Showcase Rave Omics with Biomarker Discovery in Oncology Research ..
AQ
05/23MEDIDATA : Major Cancer Center Further Advances Oncology Research by Integrating..
BU
05/21MEDIDATA : to Showcase Rave Omics with Biomarker Discovery in Oncology Research ..
BU
05/17MEDIDATA : Offers Breakthrough to De-Risk Clinical Trial Submissions
AQ
05/17MEDIDATA : PhaseBio Pharma Becomes Medidata’s 1,000th Customer, Making Com..
BU
More news
News from SeekingAlpha
06/18THE GROWTH-TEAM : Putting A Flashlight On Baozun 
06/12Medidata Solutions acquires SHYFT Analytics for $195M in cash 
05/31Deutsche Bank raises its Medidata Solutions price target 
05/21Premarket analyst action - healthcare 
05/21Medidata Solutions -1.3% on analyst downgrade 
Financials ($)
Sales 2018 641 M
EBIT 2018 130 M
Net income 2018 37,3 M
Finance 2018 228 M
Yield 2018 -
P/E ratio 2018 138,31
P/E ratio 2019 80,34
EV / Sales 2018 7,40x
EV / Sales 2019 6,16x
Capitalization 4 973 M
Chart MEDIDATA SOLUTIONS INC
Duration : Period :
Medidata Solutions Inc Technical Analysis Chart | MDSO | US58471A1051 | 4-Traders
Technical analysis trends MEDIDATA SOLUTIONS INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 85,6 $
Spread / Average Target 0,84%
EPS Revisions
Managers
NameTitle
Tarek A. Sherif Chairman & Chief Executive Officer
Glen Michael de Vries President & Director
Rouven Bergmann CFO & Principal Accounting Officer
Julie Iskow Chief Technology Officer & EVP-Product Development
Neil M. Kurtz Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MEDIDATA SOLUTIONS INC34.01%4 973
INTERNATIONAL BUSINESS MACHINES CORPORATION-7.03%132 096
ACCENTURE5.67%105 023
TATA CONSULTANCY SERVICES34.81%102 473
VMWARE, INC.21.43%61 476
AUTOMATIC DATA PROCESSING18.27%61 056